Monteris Medical Founders to Receive Pioneer in Technology Award

CathWorks FFRangio™ System Receives National Reimbursement Approval in Japan

CathWorks announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved the application to provide reimbursement for the CathWorks FFRangio™ System,...

Levine Leichtman Capital Partners Sells FlexXray

Levine Leichtman Capital Partners ("LLCP"), a Los Angeles-based private equity firm, announced today that it has sold its portfolio company FlexXray Holdings, LLC ("FlexXray" or...

Torchia and Tyc, both from Winnipeg, Manitoba, founded Monteris Medical in 1999 with the sole focus of helping patients who suffer from neurological diseases.

The revolutionary technology they developed – the minimally invasive NeuroBlate System, an MRI-guided, robotically controlled laser ablation surgical device – has been used in nearly 3,000 patients and in more than 80 institutions in the U.S. and Canada to ablate primary brain tumors, metastatic brain tumors, radiation effect and epileptic foci.

The SBMT presents this award to “the trailblazing companies and their CEOs/presidents who have facilitated the development of pioneering technologies through interdisciplinary approaches that have impacted diagnostics, treatment, and healthcare delivery in unprecedented ways.”

Torchia, who currently serves as vice-provost (teaching and learning) at the University of Manitoba in Winnipeg, said the idea for the technology came after a brain biopsy surgery he attended with a neurosurgeon. “I thought at that moment how beneficial it could be to the patient to slide a heat source down the small biopsy tract and affect some kind of change in the tumor,” said Torchia. Torchia and Tyc then began developing concepts and prototypes for laser technology use in the brain for primary tumors, using magnetic resonance imaging (MRI) as a way to monitor the heat.

Tyc, vice president of technology and advanced development at Monteris Medical, said the recognition was gratifying. “We knew then that there was tremendous potential in developing this technology,” commented Tyc. “The minimally invasive approach to the surgery and subsequent short recoveries change the game for patients that otherwise would undergo an open craniotomy or have no other option. Now, we’re looking at the technology’s next phase of development to offer hope to even more people.”

Tyc and Torchia will receive the award at the 17th Annual “Gathering for Cure” Black Tie Awards Gala of Brain Mapping Foundation, March 21 in Los Angeles.



Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.